Sherwin Stephen A's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed May 30, 2024
- Accession no.
- 0000914475-24-000160
- Filed
- May 30, 2024
- Trade date
- May 29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.34M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherwin Stephen ACIK 0001079462 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Common Stock | MOption exerciseAcquired | +25,000 | $42.76 | +$1,069,000 | 51,504 | Direct | |
| May 29, 2024 | Common Stock | SSaleDisposed | −25,000 | $133.46 | −$3,336,500 | 26,504 | Direct | |
| May 29, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $47.89 | +$718,350 | 41,504 | Direct | |
| May 29, 2024 | Common Stock | SSaleDisposed | −15,000 | $133.47 | −$2,002,050 | 26,504 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 0 | Direct | |
| May 29, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.